Methods and compositions for treatment of excess nitric oxide or cyanide toxicity
    1.
    发明授权
    Methods and compositions for treatment of excess nitric oxide or cyanide toxicity 有权
    治疗过量一氧化氮或氰化物毒性的方法和组合物

    公开(公告)号:US08431561B2

    公开(公告)日:2013-04-30

    申请号:US11630049

    申请日:2005-06-17

    IPC分类号: A61K31/555 A61K31/70

    CPC分类号: A61K31/70

    摘要: Methods for treating disease states in a subject caused or exacerbated by the presence of excess nitric oxide (NO) or excess cyanide are provided. Methods for alleviating the symptoms of a disease state in a subject caused or exacerbated by the presence of excess nitric oxide (NO) or excess cyanide in the subject are also provided. Pharmaceutical compositions comprising cobinamide and a pharmaceutically acceptable carrier are also provided.

    摘要翻译: 提供了通过过量一氧化氮(NO)或过量氰化物的存在来治疗受试者的疾病状态引起或加剧的方法。 还提供了减轻受试者中过量一氧化氮(NO)或过量氰化物的存在引起或加剧的受试者疾病状态症状的方法。 还提供了包含联苯胺酰胺和药学上可接受的载体的药物组合物。

    Nitric oxide releasing compounds
    2.
    发明授权
    Nitric oxide releasing compounds 有权
    一氧化氮释放化合物

    公开(公告)号:US08222242B2

    公开(公告)日:2012-07-17

    申请号:US12595799

    申请日:2008-04-10

    CPC分类号: A61K31/555

    摘要: Compositions comprising nitrosyl-cobinamide are provided. Also provided are methods for treating hypertension, which comprise administering therapeutically effective amounts of nitrosyl-cobinamide. Also provided are methods for producing nitrosyl-cobinamide.

    摘要翻译: 提供了包含亚硝酰基 - 叠氮酰胺的组合物。 还提供了治疗高血压的方法,其包括施用治疗有效量的亚硝酰基 - 叠氮胺。 还提供了生产亚硝酰基 - 叠氮酰胺的方法。

    Nitric Oxide Releasing Compounds
    3.
    发明申请
    Nitric Oxide Releasing Compounds 有权
    一氧化氮释放化合物

    公开(公告)号:US20100152153A1

    公开(公告)日:2010-06-17

    申请号:US12595799

    申请日:2008-04-10

    IPC分类号: A61K31/555 A61P9/12 C07F15/06

    CPC分类号: A61K31/555

    摘要: Compositions comprising nitrosyl-cobinamide are provided. Also provided are methods for treating hypertension, which comprise administering therapeutically effective amounts of nitrosyl-cobinamide. Also provided are methods for producing nitrosyl-cobinamide.

    摘要翻译: 提供了包含亚硝酰基 - 叠氮酰胺的组合物。 还提供了治疗高血压的方法,其包括施用治疗有效量的亚硝酰基 - 叠氮胺。 还提供了生产亚硝酰基 - 叠氮酰胺的方法。

    PET/SPECT AGENTS FOR APPLICATIONS IN BIOMEDICAL IMAGING
    6.
    发明申请
    PET/SPECT AGENTS FOR APPLICATIONS IN BIOMEDICAL IMAGING 有权
    PET / SPECT药剂在生物医学成像中的应用

    公开(公告)号:US20140343260A1

    公开(公告)日:2014-11-20

    申请号:US13984723

    申请日:2012-02-10

    IPC分类号: A61K51/04 C07B59/00

    摘要: Tracers that can be used for PET or SPECT imaging of the distribution of Pgp are disclosed. The tracers are metalloprobes that can comprise a radioactive metal ion such as 67Ga or 68Ga. Methods of synthesizing the tracers, and methods of imaging heart and other tissues are also disclosed. The tracers can be used to obtain high signal-to-background ratios for imaging tissues in vivo such as heart or tumor tissue. In various embodiments, disclosed tracers can exhibit, a) enhanced first pass extraction into heart tissue compared to presently available probes, b) linearity with true blood flow, c) enhanced detection of myocardial viability compared to presently available probes, d) reduced liver retention compared to presently available probes, and e) more efficient clearance from non-cardiac and adjoining tissues compared to presently available probes.

    摘要翻译: 公开了可用于Pgp分布的PET或SPECT成像的示踪剂。 示踪剂是可以包含诸如67Ga或68Ga的放射性金属离子的金属杂酚。 还公开了合成示踪剂的方法,以及心脏和其他组织成像方法。 示踪剂可用于获得体内成像组织(例如心脏或肿瘤组织)的高信噪比。 在各种实施方案中,所公开的示踪剂可以表现出:a)与目前可用的探针相比,增强的第一次通过提取到心脏组织中,b)具有真实血流的线性,c)与目前可用的探针相比增强了心肌存活力的检测,d) 与目前可用的探针相比,和e)与目前可用的探针相比,非心脏和邻近组织的更有效的清除。

    BIOLUMINESCENCE IMAGING OF MYELOPEROXIDASE ACTIVITY IN VIVO, METHODS, COMPOSITIONS AND APPARATUSES THEREFOR
    8.
    发明申请
    BIOLUMINESCENCE IMAGING OF MYELOPEROXIDASE ACTIVITY IN VIVO, METHODS, COMPOSITIONS AND APPARATUSES THEREFOR 有权
    血液中的多酚氧化酶活性的生物荧光成像,方法,组合物及其装置

    公开(公告)号:US20110250145A1

    公开(公告)日:2011-10-13

    申请号:US13127448

    申请日:2009-11-03

    CPC分类号: C12Q1/28 A61K49/0013

    摘要: Methods of imaging distribution of myeloperoxidase activity in a subject are disclosed. These methods include the use of bioluminescent substrates, including luminol and wavelength-shifted analogues of luminol. Bioluminescent myeloperoxidase substrates that emit light at longer wavelengths compared to luminol are shown to be useful for imaging myeloperoxidase activity in vivo. The disclosed methods can be used for imaging sites of inflammation and other pathological conditions associated with abnormal levels of MPO activity in vivo. Methods of synthesis of luminol analogues are also disclosed.

    摘要翻译: 公开了在受试者中成像骨髓过氧化物酶活性分布的方法。 这些方法包括使用生物发光底物,包括鲁米诺和鲁米诺的波长偏移类似物。 显示出比鲁米诺更长波长发光的生物发光髓过氧化物酶底物可用于体内髓过氧化物酶活性成像。 所公开的方法可用于与体内MPO活性异常水平相关的炎症和其他病理状况的成像部位。 还公开了鲁米诺类似物的合成方法。

    Blood brain barrier permeation peptides
    10.
    发明申请
    Blood brain barrier permeation peptides 有权
    血脑屏障渗透肽

    公开(公告)号:US20060039859A1

    公开(公告)日:2006-02-23

    申请号:US11207954

    申请日:2005-08-19

    IPC分类号: A61K51/00 C07K14/705

    摘要: Novel blood-brain barrier permeant amyloid-targeting peptides and peptide conjugates are described. The peptide conjugates include a radioisotope or other label in a stable complex that translocates across brain capillary endothelial cell monolayers. The labeled peptide conjugate binds to amyloid plaques (Aβ) associated with Alzheimer's disease, and is useful for the targeted delivery of therapeutic and diagnostic molecules into the brain.

    摘要翻译: 描述了新的血脑屏障透明性淀粉样蛋白靶向肽和肽缀合物。 肽缀合物包括易位于脑毛细血管内皮细胞单层中的稳定复合物中的放射性同位素或其他标记。 标记的肽缀合物结合与阿尔茨海默氏病相关的淀粉样蛋白斑(Abeta),并且可用于向脑中靶向递送治疗和诊断分子。